DTC Healthcare with 23andMe CEO Anne Wojcicki

episode

Motley Fool Hidden Gems Investing not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from Motley Fool Hidden Gems Investing

Oracle Calls Force Majeure Already? 26 min · 24 Sep 2026

Musings About the Agentic Future 22 min · 23 Sep 2026

The Looming Constraint of the Space Industry 23 min · 22 Sep 2026

Diesel’s All-Time High 24 min · 21 Sep 2026

Harvard's Judgment Professor: The Curse of Optionality, and the One Habit That Builds Better Judgment 32 min · 20 Sep 2026

The Current State of the Financial Independence Movement 36 min · 19 Sep 2026

All episodes from Motley Fool Hidden Gems Investing →

Report any issue

Source

Recorded24 Apr 2022

Publisherfeeds.megaphone.fm ↗

Handlerec:475890

Show notes

Genes aren’t always predictive, but understanding them better could dramatically improve our healthcare system. Motley Fool contributor Brian Orelli interviews Anne Wojcicki, the CEO of 23andMe, about her company and why it’s looking to tell you much more than the names of your long-lost relatives. They discuss: - Opportunities in direct-to-consumer healthcare - Creating more personalized medicine - The limits of genetic testing Host: Brian Orelli Guest: Anne Wojcicki Producer: Ricky Mulvey Engineers: Dan Boyd, Brandon Gentry Learn more about your ad choices. Visit megaphone.fm/adchoices

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in